Patrick Whitlow, MD

216.444.6697

Patrick Whitlow, MD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code J2-3
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
DeskDesk:216.444.6740
WorkFax:216.445.6175
Patrick Whitlow, MD
Department: Molecular Cardiology
Location: Cleveland Clinic Main Campus
Mail Code J2-3
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
DeskDesk:216.444.6740
WorkFax:216.445.6175
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Patrick L. Whitlow, MD, is Associate Director for Device Trials of C5Research and is Director of Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine.

Dr. Whitlow’s specialty interests include cardiac catheterization, peripheral vascular and coronary angiography, coronary and peripheral vascular stenting, new interventional devices, percutaneous mitral valve repair and aortic valve replacement.

Dr. Whitlow’s research interests are focused on new cardiovascular device trials. He has been the national Principal Investigator in many trials and is experienced in presenting new device applications to the FDA. Current research includes studies with drug-eluting stents, carotid revascularization, chronic total occlusions, percutaneous aortic valve replacement, percutaneous mitral valve repair, renal stenting and percutaneous lower-extremity revascularization.

He has authored or coauthored over 30 book chapters and 170 articles in leading medical journals.
After receiving his medical degree from Duke University School of Medicine, Dr. Whitlow completed residency and internship training in internal medicine at Dallas County Parkland Hospital and a fellowship in cardiovascular medicine at the University of Alabama Hospital, Birmingham. He was Catheterization Laboratory Director at University of Alabama at Birmingham before joining Cleveland Clinic in 1986.

Education & Fellowships

Fellowship - University of Alabama Hospital
Cardiovascular Diseases
Birmingham, AL USA
1981
Residency - Dallas County Hospital District-Parkland Health and Hospital
Internal Medicine
Dallas, TX USA
1979
Internship - Dallas County Hospital District-Parkland Health and Hospital
Medical Internship
Dallas, TX USA
1977
Medical School - Duke University School of Medicine
Durham, NC USA
1976
Undergraduate - University of Virginia
Charlottesville, VA USA
1972

Certifications

  • Internal Medicine
  • Internal Medicine- Cardiovascular Disease

Specialty Interests

Coronary artery disease, stent restenosis, total coronary occlusions, angioplasty, rotational atherectomy, stent-coronary, coronary artery atherectomy, coronary intervention, drug eluting stenting

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/19/2013, Dr. Whitlow has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Whitlow received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Frantz Medical Ventures

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site